A preliminary operational classification system for nonmutagenic modes of action for carcinogenesis

D Hattis1, M Chu, N Rahmioglu

  • 1George Perkins Marsh Institute, Clark University, Worcester, Massachusetts, USA.

Insights

This study introduces a classification system for nonmutagenic carcinogenesis modes of action, categorizing them into co-initiation, promotion, progression, and multiphase actions. Understanding these mechanisms can help predict cancer risk based on exposure timing.

Area of Science:

  • Toxicology
  • Carcinogenesis Research
  • Molecular Biology

Background:

  • Carcinogenesis involves complex, multi-step processes.
  • Nonmutagenic mechanisms play a significant role in cancer development.
  • Existing classifications may not fully capture the diverse modes of action.

Purpose of the Study:

  • To propose a systematic categorization of nonmutagenic modes of action in carcinogenesis.
  • To differentiate between various mechanisms contributing to cancer development.
  • To provide a framework for understanding how different agents influence cancer initiation, promotion, and progression.

Main Methods:

  • Development of a classification system based on distinct modes of action.
  • Categorization of mechanisms including co-initiation, promotion, progression, and multiphase actions.
  • Examples provided for each category, such as enzyme induction, altered cell communication, immune suppression, and epigenetic silencing.

Main Results:

  • A four-category system for nonmutagenic carcinogenesis modes of action is presented: co-initiation, promotion, progression, and multiphase.
  • Co-initiation involves facilitating mutagenic changes, promotion enhances initiated cell growth, progression aids tumor development and spread, and multiphase actions encompass broader effects like epigenetic silencing.
  • The timing of exposure relative to the stage of action (early vs. late) is linked to susceptibility.

Conclusions:

  • The proposed classification provides a structured approach to understanding nonmutagenic carcinogenesis.
  • This framework aids in identifying and characterizing agents that contribute to cancer through non-DNA-damaging pathways.
  • Susceptibility to carcinogens acting via different modes may vary with age, correlating with the stage of action in the carcinogenic process.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cellular Adaptation IV: Dysplasia and Metaplasia01:24

Cellular Adaptation IV: Dysplasia and Metaplasia

DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...